Production (Stage)
Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 635.20K | 645.50K | 671.10K | 674.60K | 445.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 635.20K | 645.50K | 671.10K | 674.60K | 445.30K |
| Cost of Revenue | 195.30K | 198.50K | 222.70K | 223.80K | 198.70K |
| Gross Profit | 439.90K | 447.00K | 448.50K | 450.80K | 246.60K |
| SG&A Expenses | 479.60K | 487.30K | 541.80K | 544.60K | 432.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 10.20K | 10.40K | -- | -- | -82.00K |
| Total Operating Expenses | 883.70K | 897.90K | 949.90K | 954.80K | 612.40K |
| Operating Income | -248.40K | -252.50K | -278.80K | -280.20K | -167.10K |
| Income Before Tax | -801.10K | -814.00K | -344.40K | -346.20K | -463.30K |
| Income Tax Expenses | -- | -- | -- | -- | -600.00 |
| Earnings from Continuing Operations | -801.10K | -814.00K | -344.40K | -346.20K | -462.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -801.10K | -814.00K | -344.40K | -346.20K | -462.70K |
| EBIT | -248.40K | -252.50K | -278.80K | -280.20K | -167.10K |
| EBITDA | -241.10K | -239.00K | -254.20K | -255.50K | -152.80K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.90B | 1.90B | 1.89B | 1.89B | 1.66B |
| Average Diluted Shares Outstanding | 1.90B | 1.90B | 1.89B | 1.89B | 1.66B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |